Together we will beat cancer

Donate

Our milestones: Cisplatin – the story of a platinum-selling life-saver

Category: Science blog August 26, 2015 Comments are closed

This entry is part 23 of 29 in the series Our milestones

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

Read More

Cancer survival in England is improving – but still lagging behind similar countries

Category: Science blog August 5, 2015 Comments are closed

We explore new data showing that cancer survival in England remains lower than countries with similar healthcare systems.

Read More

Shape-shifting molecular cousins are the key to DNA repair

Category: Science blog July 20, 2015 Comments are closed

It’s taken years of frustration and dedication (not to mention countless hours spent in a small room roughly the temperature…

Read More

Cancer killer combination could make cells more sensitive to chemo

Category: Science blog July 15, 2015 Comments are closed

How our researchers in Manchester are helping develop ways to make chemotherapy kinder and more effective.

Read More

A disappointing decision over olaparib for ovarian cancer

Category: Science blog June 1, 2015 4 comments

In light of a preliminary ‘no’ from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug’s development

Read More

New ovarian cancer blood test is promising – but screening still a way off

Category: Science blog May 5, 2015 11 comments

We look at headlines about a new blood test for ovarian cancer, and why a possible routine screening test for the disease is still some way off.

Read More

Unpicking the genetic ‘patchwork’ in ovarian cancer

Category: Science blog March 12, 2015 17 comments

Our researchers are investigating the genetic ‘patchwork’ underlying ovarian tumours, which will lead to more effective treatments in the future.

Read More

Lethal Weapon Too: Using DNA repair processes to target cancer

Category: Science blog February 24, 2015 2 comments

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

Read More

Coming ever closer – first PARP inhibitor licensed in Europe

Category: Science blog October 24, 2014 5 comments

Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

Read More

A year of research – and 13 milestones you helped fund

Category: Science blog July 25, 2014 25 comments

To coincide with the publication of our Annual Review, here are some of the key research milestones that our amazing supporters have helped fund.

Read More